Widschwendter, M; Burnell, M; Fraser, L; Rosenthal, AN; Philpott, S; Reisel, D; Dubeau, L; ... Dougall, WC; + view all (2015) Osteoprotegerin (OPG), the endogenous inhibitor of receptor activator of NF-κB ligand (RANKL), is dysregulated in BRCA mutation carriers. EBioMedicine , 2 (10) pp. 1331-1339. 10.1016/j.ebiom.2015.08.037. Green open access